C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/495 (2006.01) C07D 231/00 (2006.01) C07D 239/00 (2006.01) C07D 251/00 (2006.01)
Patent
CA 2314613
Corticotropin releasing factor (CRF) antagonists of formula (I) or (II) and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
L'invention concerne des antagonistes de facteur de libération de corticotrophine (CRF) de la formule (I) ou (II) et leur utilisation dans le traitement de l'anxiété, de la dépression et d'autres troubles psychiatriques et neurologiques, ainsi que le traitement d'affections immunologiques, cardiovasculaires ou liées au coeur et de l'hypersensibilité du côlon associée à des troubles psychopathologiques et au stress.
Arvanitis Argyrios Georgios
Chorvat Robert
Gilligan Paul
Liqi He
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
Du Pont Pharmaceuticals Company
LandOfFree
Azolo triazines and pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azolo triazines and pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azolo triazines and pyrimidines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1573423